Skip to main content
Log in

Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A large number of lung cancers contains and releases a variety of neuropeptides such as adrenocorticotropic hormone (ACTH) and β-endorphin (β-EP). Although the plasma levels of these peptides have been extensively investigated as possible markers that may help in the early diagnosis of the disease, the data collected have shown their limited clinical usefulness. The present study was undertaken to evaluate whether corticotropin-releasing hormone (CRH), ACTH or β-EP levels in thebronchoalveolar lavage (BAL) fluid of patients with lung cancer might have been more helpful. To accomplish this, bronchial lavages were carried out in 25 patients affected by lung cancer (17 squamous carcinomas, 4 adenocarcinomas, 2 small cell carcinomas, and 2 not classified) and 18 controls. After centrifugation, BAL fluid was extracted using cartridges of SepPak C-18 and CRH, ACTH and β-EP levels were measured by radioimmunoassay. CRH and ACTH BAL levels in patients with lung cancer were not significantly different from those of controls. β-EP concentrations in the BAL fluid were about 200-fold higher than those of ACTH and showed a downward trend (p=0.08, Mann-Whitney test) in patients with cancer. No histologic tumor type was associated with particurarly elevated levels of any of the peptides measured, not even the two patients with small cell carcinoma, a tumor type which tends to release higher peptide levels. Therefore we conclude that measurements of CRH, ACTH and/or β-EP in the BAL fluid are not useful diagnostic tumor markers of lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ratcliffe J.G. ACTH and related peptides in lung cancer. In: Recent Results in Cancer Research Springer-Verlag, Berlin, 1985, vol. 99, pag. 46.

    Google Scholar 

  2. Broder L.E. Hormone production by bronchogenic carcinoma: a review. Pathobiol. Ann. 9: 205, 1979

    CAS  Google Scholar 

  3. Bondy P.K., Gilby E.D. Endocrine function of small cell undifferentiated carcinoma of the lung. Cancer 50: 2147, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Bork E., Hansen M., Urdal P., Paus E., Holst J.J., Schifter S., Fenger M., Engbaek F. Early detection of response in small cell bronchogenic carcinoma by changes in serum concentrations of creatinine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin-releasing peptide. Eur. J. Cancer Clin. Oncol. 24: 1033, 1988.

    Article  PubMed  CAS  Google Scholar 

  5. Winkelman W., Deub U., Allolio B., Hummerich W., Kaulen D., Brosch H., Guyot A., Arnold C. Adrenocorticotropin, calcitonin, and adiuretic hormone as tumor markers in patients with bronchogenic carcinoma of various histological types. Klin. Wochenschr. 62: 1018, 1984.

    Article  Google Scholar 

  6. Ayvaian L.F., Schneider B., Gewirtz G., Yalow R.S. Ectopic production of big ACTH in carcinoma of the lung:its clinical usefulness as a biological marker. Am. Rev. Dis. 111: 279, 1975.

    Google Scholar 

  7. Bondy P.K. The pattern of ectopic hormone production in lung cancer. Yale J. Biol. Med. 54: 181, 1981.

    PubMed Central  PubMed  CAS  Google Scholar 

  8. Calogero A.E., Minacapilli G., Nicolosi A.M.G., Moncada M.L., Mistretta A., Latteri S.F., Polosa P., D’Agata R. Limited clinical usefulness of plasma corticotropin-releasing hormone, ACTH and β-endorphin measurements as markers of lung cancer. J. Endocrinol. Invest. 15: 581, 1992.

    Article  PubMed  CAS  Google Scholar 

  9. Torstensson S., Thoren M., Hall K. Plasma ACTH in patients with bronchogenic carcinoma. Acta Med. Scand. 207: 353, 1980.

    Article  PubMed  CAS  Google Scholar 

  10. Wolfsen A.E., Odell W.D. Pro ACTH: use for early detection of lung cancer. Am. J. Med. 66: 765, 1979.

    Article  PubMed  CAS  Google Scholar 

  11. Mountain C.F. A new international staging system for lung cancer. Chest 89: 225, 1986.

    Article  Google Scholar 

  12. Calogero A.E., Kamilaris T.C., Gomez M.T., Johnson E.O., Tartaglia M.E., Gold P.W., Chrousos G.P. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal is through a centrally-mediated corticotropin-releasing hormone-dependent mechanism. Endocrinology 125: 2445, 1989.

    Article  PubMed  CAS  Google Scholar 

  13. Bagdy G., Calogero A.E., Chrousos G.P., Szemeredi K. Delayed effects of chronic cortisol treatment on brain and plasma concentrations of corticotropin (ACTH) and β-endorphin. Brain Res. 489: 216, 1988.

    Article  Google Scholar 

  14. Reynolds H.Y. Bronchoalveolar lavage. Am. Rev. Respir. Dis. 135: 250, 1987.

    PubMed  CAS  Google Scholar 

  15. Smith D.L., Deshazo R.D. Bronchoalveolar lavage in asthma. An update and perspective. Am. Rev. Respir. Dis. 148: 523, 1993.

    Article  PubMed  CAS  Google Scholar 

  16. Doppman J.L., Pass H.I., Nieman L., Cutler G.B. Jr., Chrousos G.P., Loriaux D.L. Failure of bronchial lavage to detect elevated levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids. J. Clin. Endocrinol. Metab. 69: 1302, 1989.

    Article  PubMed  CAS  Google Scholar 

  17. Nieber K., Baumgarten C.R., Rathsack R., Furkert J., Oehme P., Kunkel G. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90: 646, 1992.

    Article  PubMed  CAS  Google Scholar 

  18. Hansen M., Hansen H.H. Tumor markers in the clinical management of patients with small cell lung cancer. Eur. Respir. J. 2: 700, 1989.

    Google Scholar 

  19. Calogero A.E., Norton J.A., Sheppard B.C., Listwak S.J., Cromack D.T., Wally R., Jensen R.T., Chrousos G.P. Pulsatile activation of the hypothalamic-pituitary-adrenal axis during major surgery. Metabolism 41: 839, 1992.

    Article  PubMed  CAS  Google Scholar 

  20. Aguayo S.M., Kane M.A., King T.E. Jr., Schwarz M.I., Grauer L., Miller Y.E. Increased levels of bombesin-like peptides in the lower respiratory tract of asymptomatic cigarette smokers. J.Clin. Invest. 84: 1105, 1989.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  21. Idell S., Garcia J.G.N., Gonzales K., McLarty J., Fair D.S. Fibrinopeptide A reactive peptides and procoagulant activity in the bronchoalveolar lavage: relationship to rheumatoid intersitial lung disease. J. Rheumatol. 16: 592, 1989.

    PubMed  CAS  Google Scholar 

  22. Yamauchi K., Martinet Y., Basset P., Fells G.A., Crystal R.G. High levels of transforming growth factor-β are present in the epithelial lining fluid of the normal respiratory tract. Am. Rev. Respir. Dis. 137: 1360, 1988.

    Article  PubMed  CAS  Google Scholar 

  23. Aguayo S.M., Kane M.A., King T.E., Jr., Miller Y.E. In vitro degradation of bombesin by human plasma, urine and bronchoalveolar lavage fluid. Clin. Res. 36: 502A, 1988 (abstract).

    Google Scholar 

  24. DeBold C.R., Nicholson W.E., Orth D.N. Immunoreactive proopiomelanocortin (POMC) peptides and POMC-like messenger ribonucleic acid are present in many rat nonpituitary tissues. Endocrinology 122: 2648, 1988.

    Article  PubMed  CAS  Google Scholar 

  25. Ruff M., Schiffmann E., Terrannova V., Pert C.B. Neuropeptides are chemoattractants for human tumor cells and monocytes: a possible mechanism for metastasis. Clin. Immunol. Immunopathol. 37: 387, 1985.

    Article  PubMed  CAS  Google Scholar 

  26. Almqvist P.M., Knigge K.M., Kuenzig M., Joseph S.A., Richer W.H., Schwartz S.I. Pulmonary platelet trapping induced by β-endorphin injection in the cerebrospinal fluid in dogs. Surgery 98: 344, 1986.

    Google Scholar 

  27. Ekstrom B.F., Kuwnzig M., Schwartz S.I. Pulmonary platelet trapping in Escherichia coli endotoxin-injected dogs treated with methylpred-nisolone, ibuprofen and naloxone. Acta Chir. Scand. 152: 181, 1986.

    PubMed  CAS  Google Scholar 

  28. Maneckjee R., Minna J.D. Opiod and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc. Natl. Acad. Sci. (USA) 87: 3294, 1990.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This study was supported lin part by a grant from MURST, Fellowship in Internal Medicine

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calogero, A.E., Polosa, R., Neville, E. et al. Measurements of hormonal peptides in the bronchoalveolar fluid as tumor markers of lung cancer. J Endocrinol Invest 18, 354–358 (1995). https://doi.org/10.1007/BF03347837

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347837

Key-words

Navigation